News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
Penny Stocks
News
DMTTF
From
Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
Tags
USPTO
Penny Stocks
News
From
Benzinga
Healthcare Providers Can Offer Ketamine Treatment On Employee Insurance Plans
September 20, 2023
Tags
Psychedelics
Benzinga
Enthea
From
Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
September 20, 2023
Tags
Psychedelics Reform
Psychedelic/Assisted Therapies
General
From
Benzinga
Kentucky's $42M Ibogaine Budget Plan For Opioid Crisis Hears Testimonies At Second Meeting
September 19, 2023
Tags
Psychedelic/Assisted Therapies
Markets
Market News
From
Benzinga
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
Tickers
ATAI
CMND
CMPS
DRUG
Tags
IXHL
CMPS
Psychedelic/Assisted Therapies
From
Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
Benzinga
Psychedelics
Postpartum Depression
From
Benzinga
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update
September 18, 2023
Tickers
ATAI
CYBN
DMTTF
MNMD
Tags
News
DMTTF
ATAI
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
Legal
Psychedelic/Assisted Therapies
FDA
From
Benzinga
Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows
September 13, 2023
Tickers
MNMD
Tags
NYU Langone's Center for Psychedelic Medicine
MDMA dosing
Psychedelic/Assisted Therapies
From
Benzinga
Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative
September 13, 2023
Tickers
CMPS
Tags
News
Markets
Sweden Psychedelics
From
Benzinga
Congress Update: House Committee Green Lights Psychedelics Amendments
September 13, 2023
Tags
News
Cannabis
federal marijuana reform
From
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
Tickers
ATAI
CMPS
CYBN
JAZZ
Tags
NUMIF
JNJ
Market News
From
Benzinga
Michigan Resolution: Veterans Across US Should Have Access To Psychedelic-Assisted Therapy
September 08, 2023
Tags
Management
Psychedelics Reform
Psychedelic/Assisted Therapies
From
Benzinga
'Wolf Of Wall Street' Embraces Ibogaine For Addiction Recovery With Help Of 'Psychedelic Concierge'
September 08, 2023
Tags
Markets
Cannabis
Market News
From
Benzinga
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
September 08, 2023
Tickers
OPTHF
Tags
Guidance
News
Penny Stocks
From
Benzinga
Shaping Federal Policy Around Psychedelic Therapy: APPA Teams Up With Daschle Group
September 07, 2023
Tags
Legal
FDA
Psychedelic/Assisted Therapies
From
Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
September 07, 2023
Tags
Benzinga
Psychedelics
Psilocybin program
From
Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
September 06, 2023
Tickers
CMND
Tags
Cannabis
Johns Hopkins University
Market News
From
Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
September 06, 2023
Tickers
PHRRF
Tags
Abbreviated New Drug Application
Drug Delivery Technologies
Cannabis
From
Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
September 06, 2023
Tickers
CMPS
Tags
treatment/resistant depression
Cannabis
Market News
From
Benzinga
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
September 05, 2023
Tickers
CYBN
DMTTF
Tags
Psychedelics
Benzinga
Tryptamines
From
Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Tickers
ATAI
BRAXF
CMPS
CYBN
Tags
SEEL
Market News
PSIL
From
Benzinga
Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market
September 04, 2023
Tags
Lophos Holdings Inc/
Psychedelics
Benzinga
From
Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
Tags
Psychedelic/Assisted Therapies
The Usona Institute
Psilocybin program
From
Benzinga
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
September 01, 2023
Tickers
JNJ
Tags
Ketamine Therapy
News
JNJ
From
Benzinga
UK Psychedelics Update: MPs Seek Rescheduling, Safe Consumption Sites, OD Prevention Fund
September 01, 2023
Tickers
UK
Tags
Cannabis
Market News
Markets
From
Benzinga
Colorado's Psychedelic Future Unfolds: Regulators Host Community Meetings To Shape Industry Rules
August 31, 2023
Tags
Markets
Cannabis
Colorado Psychedelics
From
Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
August 31, 2023
Tickers
CYBN
DMTTF
MSSTF
NUGL
Tags
Penny Stocks
DMTTF
SILFF
From
Benzinga
Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
August 31, 2023
Tickers
BRAXF
Tags
Management
KetaMD Inc/
Financing
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.